最近几年,医药股和科技股的讨论度都不低。对于普通投资者,它们真的值得投资吗?富达基金掌舵人、被誉为彼得·林奇的衣钵传人的乔尔·蒂林哈斯特在他的著作《大钱细思》...查看全文
Pnmk2016-08-22 23:44
$麦迪韦逊医疗(MDVN)$ 辉瑞的收购激活了潜在的生物科技股:BMRN 和sanofi 传闻,血癌药商INCY,ALXN,VRTX。这些都是概率较大的被收购公司查看全文
an小安2016-08-22 19:31
$辉瑞(PFE)$ $麦迪韦逊医疗(MDVN)$
辉瑞官方消息出来了:Pfizer To Acquire Medivation Propels Pfizer into a leading position in oncology
Medivation agrees to transaction valued at $81.50 per Medivation share in cash, for a total enterprise value of approximately $14 billio...查看全文
张小丰2016-08-17 18:55
回复@洗水标: 我认为不是这么回事。
通常一个重磅在研药临床结果很好的时候股价会一波涨100%以上。
然后等这个药开卖以后如果放量达到预期那么股价还会继续一直涨的。。
比如再生元的Eylea获批以后股价暴涨一波。但是等Eylea逐渐放量到今天还是又继续涨了4倍左右。
麦迪韦逊医疗也...查看全文
$麦迪韦逊医疗(MDVN)$ DEFC14A - Definitive proxy statement, contested solicitations Filed: 2016-06-13 AccNo: 0001193125-16-619498 Size: 357 KB 网页链接
$麦迪韦逊医疗(MDVN)$ DEFC14A - Definitive proxy statement, contested solicitations Filed: 2016-06-13 AccNo: 0001193125-16-619485 Size: 1 MB 网页链接
$麦迪韦逊医疗(MDVN)$ PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise Filed: 2016-06-09 AccNo: 0001193125-16-617365 Size: 353 KB 网页链接
$麦迪韦逊医疗(MDVN)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2016-06-09 AccNo: 0001193125-16-617078 Size: 1 MB 网页链接
$麦迪韦逊医疗(MDVN)$ DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Filed: 2016-06-08 AccNo: 0001193125-16-615890 Size: 41 KB 网页链接
$麦迪韦逊医疗(MDVN)$ DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Filed: 2016-06-08 AccNo: 0001193125-16-615887 Size: 1 MB 网页链接
$麦迪韦逊医疗(MDVN)$ PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise Filed: 2016-06-07 AccNo: 0001193125-16-614351 Size: 311 KB 网页链接
$麦迪韦逊医疗(MDVN)$ 内部交易: 2016-06-06,SVP, General Counsel & Crp Sec,Powell Andrew Kenneth William ,卖出,2578普通股, $60.42
$麦迪韦逊医疗(MDVN)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2016-06-06 AccNo: 0001193125-16-614150 Size: 1 MB 网页链接
$麦迪韦逊医疗(MDVN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-06-06 AccNo: 0001193125-16-612980 Size: 22 MB 网页链接